Drugs for COVID-19: An Update

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceramella, Jessica, Iacopetta, Domenico, Sinicropi, Maria Stefania, Andreu, Inmaculada, Mariconda, Annaluisa, Saturnino, Carmela, Giuzio, Federica, Longo, Pasquale, Aquaro, Stefano, Catalano, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740261/
https://www.ncbi.nlm.nih.gov/pubmed/36500655
http://dx.doi.org/10.3390/molecules27238562
Descripción
Sumario:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.

Ejemplares similares